For Nasotracheal Intubation With Video Rigid Stylet, Which Nostril is Better?

April 27, 2022 updated by: Yang Xudong, Peking University

For Nasotracheal Intubation With Video Rigid Stylet, Which Nostril is Better? A Randomized Clinical Trial

To determine which nostril is more suitable for nasotracheal intubation with video rigid stylet.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Head and neck surgeries usually require nasal intubation, which allows leeway for operative maneuvering in the mouth, pharynx, larynx, and neck. Previous studies have found that the right nostril is more appropriate for nasal intubation using direct laryngoscope or videolaryngoscope. It has been shown that the optical rigid stylet was also an appropriate tool for nasal intubation. However, nasal intubation with rigid optical stylet is technically different from that with laryngoscope. It is unknown whether the choice of nostril could affect the intubation using rigid optical stylet. The main aim is to determine which nostril is more suitable for nasal intubation with video rigid stylet.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beijing, China
        • Peking University Hospital of stomatology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age ≥ 18 years;
  2. American Society of Anesthesiologists physical status I~II;
  3. Scheduled to undergo elective oral and maxillofacial surgery requires nasal intubation;
  4. The expected operation time < 3 hours;
  5. Extubation in operation room and do not scheduled to preventive tracheotomy;
  6. Patients who were able to breathe clearly and equally through both nostrils.

Exclusion Criteria:

  1. Patients had history of difficult intubation or presented with an anticipated difficult airway;
  2. Patients requiring nasogastric tube insertion;
  3. Presence of contraindications of nasal intubation;
  4. Due to surgical requirement, intubation must be completed through one nostril;
  5. Presence of severe nasal obstruction,deformities of the nasal cavity, or other serious nasal diseases;
  6. History of severe epistaxis or epistaxis within a month;
  7. Previous history of nasal and/or laryngeal surgery;
  8. Previous experience with nasal intubation;
  9. History of schizophrenia, Parkinson's disease or profound dementia, or language barrier;
  10. Participate in other clinical studies;
  11. Refusal to sign informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Right nostril group
Nasal intubation with video rigid stylet was performed through the right nostril.
Nasal intubation was performed using the video rigid stylet.
Placebo Comparator: Left nostril group
Nasal intubation with video rigid stylet was performed through the left nostril.
Nasal intubation was performed using the video rigid stylet.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total time for intubation
Time Frame: Procedure (From when the device tip entered the nostril to when the tube entered the trachea.)
The duration from when the device tip entered the nostril to when the tube entered the trachea, as confirmed by capnography.
Procedure (From when the device tip entered the nostril to when the tube entered the trachea.)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total success rate
Time Frame: Procedure (Up to the tube entered the trachea.)
Total success rate of nasal intubation with video rigid stylet.
Procedure (Up to the tube entered the trachea.)
First-attempt success
Time Frame: First-attempt of nasal intubation with video rigid stylet.
First-attempt success of nasal intubation with video rigid stylet.
First-attempt of nasal intubation with video rigid stylet.
Times of intubation-attempts
Time Frame: Procedure (From when the device tip entered the nostril to when the tube entered the trachea.)
Times of intubation-attempts.
Procedure (From when the device tip entered the nostril to when the tube entered the trachea.)
The time for device insertion
Time Frame: Procedure (From when the device tip entered the nostril to when it passed through the vocal cord.)
The duration from when the device tip entered the nostril to when it passed through the vocal cord.
Procedure (From when the device tip entered the nostril to when it passed through the vocal cord.)
The time for tube insertion
Time Frame: Procedure (From when the tip of the device passed through the vocal cord to when the tube was confirmed inserted into the trachea.)
The duration from when the tip of the device passed through the vocal cord to when the tube was confirmed inserted into the trachea.
Procedure (From when the tip of the device passed through the vocal cord to when the tube was confirmed inserted into the trachea.)
Incidence and severity of epistaxis
Time Frame: Procedure (Up to completion of intubation)
Incidence and severity of epistaxis
Procedure (Up to completion of intubation)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intubation related adverse events.
Time Frame: Up to 24 hours after intubation.
Safety outcome
Up to 24 hours after intubation.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Xudong Yang, MD, PhD, Peking University School and Hospital of Stomatology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 8, 2022

Primary Completion (Actual)

April 15, 2022

Study Completion (Actual)

April 16, 2022

Study Registration Dates

First Submitted

January 30, 2022

First Submitted That Met QC Criteria

January 31, 2022

First Posted (Actual)

February 1, 2022

Study Record Updates

Last Update Posted (Actual)

April 29, 2022

Last Update Submitted That Met QC Criteria

April 27, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe